SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-012298
Filing Date
2018-09-10
Accepted
2018-09-07 20:54:33
Documents
59
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_adialpharma.htm 10-Q 797335
2 FORM OF UNIT WARRANT f10q0618ex4-1_adialpharma.htm EX-4.1 112145
3 CERTIFICATION f10q0618ex31-1_adialpharma.htm EX-31.1 19459
4 CERTIFICATION f10q0618ex31-2_adialpharma.htm EX-31.2 19089
5 CERTIFICATION f10q0618ex32-1_adialpharma.htm EX-32.1 5876
6 CERTIFICATION f10q0618ex32-2_adialpharma.htm EX-32.2 5687
7 GRAPHIC img_001.jpg GRAPHIC 71706
  Complete submission text file 0001213900-18-012298.txt   3711552

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE adil-20180630.xml EX-101.INS 409564
9 XBRL SCHEMA FILE adil-20180630.xsd EX-101.SCH 42904
10 XBRL CALCULATION FILE adil-20180630_cal.xml EX-101.CAL 36973
11 XBRL DEFINITION FILE adil-20180630_def.xml EX-101.DEF 169830
12 XBRL LABEL FILE adil-20180630_lab.xml EX-101.LAB 314614
13 XBRL PRESENTATION FILE adil-20180630_pre.xml EX-101.PRE 250714
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 181061252
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1